US Patents for PCT: WO2007/058627
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sobi | VONJO | pacritinib citrate | CAPSULE;ORAL | 208712-001 | Feb 28, 2022 | RX | Yes | Yes | 8,153,632 | ⤷ Get Started Free | Y | Y | TREATMENT OF MYELOFIBROSIS WITH PACRITINIB | ||
| Sobi | VONJO | pacritinib citrate | CAPSULE;ORAL | 208712-001 | Feb 28, 2022 | RX | Yes | Yes | 8,153,632 | ⤷ Get Started Free | Y | Y | USE OF PACRITINIB FOR INHIBITING JANUS ASSOCIATED KINASE 2(JAK2) | ||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use |
